069620.KS KSC
Daewoong pharmaceutical Co.,Ltd
1W: +2.6%
1M: -14.0%
3M: -7.9%
YTD: -39.1%
1Y: -18.7%
3Y: +13.3%
5Y: -37.1%
₩109,000.00 ($81.15)
-600.00 (-0.55%)
Weekly Expected Move ±4.8%
₩98556
₩103778
₩109000
₩114222
₩119444
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTM₩1,635B
Revenue
+9.9% YoY
₩195B
Net Income
+160.3% YoY
₩-117,443M
Free Cash Flow
-47.5% YoY
53.6%
Gross Margin
15.2%
Op. Margin
7.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE20.6%
ROA8.4%
ROIC10.3%
Valuation
P/E6.4
P/B1.2
EV/EBITDA8.1
Leverage
Debt/Equity0.87
Current Ratio0.89
Interest Cov.12.9x
Quality Scores
Piotroski F4/9
Altman Z1.91
Beneish M-2.27